Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Takeshi Funakoshi
Ataxia Telangiectasia and Rad3 Related (ATR)-promyelocytic Leukemia Protein (PML) Pathway of the DNA Damage Response in the Brain of Rats Administered Arsenic Trioxide
Journal of Toxicologic Pathology
Forensic Medicine
Toxicology
Pathology
Activation of Master Autophagy Regulator TFEB During Systemic LPS Administration in the Cornea
Journal of Toxicologic Pathology
Forensic Medicine
Toxicology
Pathology
Related publications
The Ataxia-Telangiectasia Related Protein ATR Mediates DNA-dependent Phosphorylation of P53
Oncogene
Cancer Research
Genetics
Molecular Biology
Clinicopathological Significance of Ataxia Telangiectasia-Mutated (ATM) Kinase and Ataxia Telangiectasia-Mutated and Rad3-Related (ATR) Kinase in MYC Overexpressed Breast Cancers
Breast Cancer Research and Treatment
Cancer Research
Oncology
The Role of the DNA Damage Response in Ataxia-Telangiectasia Syndrome
Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells
PLoS ONE
Multidisciplinary
A Proteomic Analysis of Ataxia Telangiectasia-Mutated (ATM)/ATM-Rad3-related (ATR) Substrates Identifies the Ubiquitin-Proteasome System as a Regulator for DNA Damage Checkpoints
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Impact of Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Analysis of Mutations That Dissociate G2and Essential S Phase Functions of Human Ataxia Telangiectasia-Mutated and Rad3-Related (ATR) Protein Kinase
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Inhibition of Ataxia-Telangiectasia Mutated and RAD3-related (ATR) Overcomes Oxaliplatin Resistance and Promotes Anti-Tumor Immunity in Colorectal Cancer.
Cancer Research
Cancer Research
Oncology
Retinoic Acid and Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia: Current Perspectives
OncoTargets and Therapy
Oncology
Pharmacology
